These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2258662)

  • 21. [Detection of activated oncogenes by Southern blot analysis].
    Urabe K; Sasazuki T
    Nihon Rinsho; 1990 Aug; 48(8):187-92. PubMed ID: 2255080
    [No Abstract]   [Full Text] [Related]  

  • 22. [Application of polymerase chain reaction (PCR) to detect activated oncogenes].
    Ishikawa F
    Nihon Rinsho; 1990 Aug; 48(8):156-62. PubMed ID: 2255075
    [No Abstract]   [Full Text] [Related]  

  • 23. Oncogenes in multiple myeloma: point mutation of N-ras.
    Paquette RL; Berenson J; Lichtenstein A; McCormick F; Koeffler HP
    Oncogene; 1990 Nov; 5(11):1659-63. PubMed ID: 2267133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of cellular oncogene rearrangement or amplification in ovarian adenocarcinomas.
    Smith DM; Groff DE; Pokul RK; Bear JL; Delgado G
    Am J Obstet Gynecol; 1989 Oct; 161(4):911-5. PubMed ID: 2801838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of minimal acute myeloid leukemia cells in bone marrow by probing for mutated ras oncogenes using the polymerase chain reaction.
    Ball ED; Mills LE; Neubauer A; Liu E
    Prog Clin Biol Res; 1990; 333():499-506. PubMed ID: 2408063
    [No Abstract]   [Full Text] [Related]  

  • 26. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
    Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
    Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
    Minamoto T; Mai M; Ronai Z
    Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alterations in proto-oncogenes c-myc, Ha-ras and Ki-ras in experimental mesothelioma in rats].
    Kleĭmenova EV; Khoresovski i G; Vasil'eva LA; Iakubovskaia MG; Pylev LN
    Biull Eksp Biol Med; 1995 Oct; 120(10):414-7. PubMed ID: 8595236
    [No Abstract]   [Full Text] [Related]  

  • 29. Presence of mutations in all three ras genes in human thyroid tumors.
    Suarez HG; du Villard JA; Severino M; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
    Oncogene; 1990 Apr; 5(4):565-70. PubMed ID: 2183158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ras oncogene activation in human ovarian carcinoma.
    van 't Veer LJ; Hermens R; van den Berg-Bakker LA; Cheng NC; Fleuren GJ; Bos JL; Cleton FJ; Schrier PI
    Oncogene; 1988 Feb; 2(2):157-65. PubMed ID: 3285294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular pathology of oncogenes and anti-oncogenes in diagnosis of colonic polyps].
    Monden T; Morimoto H; Nakanishi H; Fukunaga M; Shimano T; Mori T
    Nihon Rinsho; 1991 Dec; 49(12):88-96. PubMed ID: 1787590
    [No Abstract]   [Full Text] [Related]  

  • 32. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
    Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
    Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved detection of K-ras codon 12 mutations in fecal exfoliated cells.
    Puig P; Urgell E; Capellá G; Villanueva A; Grau M; Sancho FJ; Pujol J; Lluís F; González-Sastre F; Mora J
    Lab Invest; 1999 May; 79(5):617-8. PubMed ID: 10334573
    [No Abstract]   [Full Text] [Related]  

  • 34. Sampling method as a key factor in identifying K-ras oncogene mutations in preneoplastic colorectal lesions.
    Ronai Z; Minamoto T; Butler R; Tobi M; Luo FQ; Zang E; Esumi H; Sugimura T
    Cancer Detect Prev; 1995; 19(6):512-7. PubMed ID: 8925520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A gene from human chromosome region 3p21 with reduced expression in small cell lung cancer.
    Carritt B; Kok K; van den Berg A; Osinga J; Pilz A; Hofstra RM; Davis MB; van der Veen AY; Rabbitts PH; Gulati K
    Cancer Res; 1992 Mar; 52(6):1536-41. PubMed ID: 1311632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
    Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K
    Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of degenerate oligonucleotide-primed polymerase chain reaction amplification and labeling methods on the sensitivity and specificity of metaphase- and array-based comparative genomic hybridization.
    Tsubosa Y; Sugihara H; Mukaisho K; Kamitani S; Peng DF; Ling ZQ; Tani T; Hattori T
    Cancer Genet Cytogenet; 2005 Apr; 158(2):156-66. PubMed ID: 15796963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genetic diagnosis for leukemias by oncogenes].
    Ishikawa F; Hirai H
    Nihon Naika Gakkai Zasshi; 1990 Sep; 79(9):1179-82. PubMed ID: 2258663
    [No Abstract]   [Full Text] [Related]  

  • 39. [Gene diagnosis and oncogenes of leukemia].
    Inokuchi K
    Nihon Ika Daigaku Zasshi; 1991 Dec; 58(6):708-12. PubMed ID: 1770122
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of point mutations in p21ras genes.
    Bos JL; Van Mansfeld AD
    Ann Med; 1992 Jun; 24(3):207-9. PubMed ID: 1352688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.